News Summary

St. Michael’s Hospital in Toronto has received funding for the MIMOSA Pro device, a digital health innovation designed to improve the treatment of diabetic foot ulcers. Developed by Dr. Karen Cross and Dr. General Leung, the device uses visible, infrared, and near-infrared light to capture detailed wound insights, aiding clinicians in better assessing and treating wounds. The funding was secured through Ontario Health and Boehringer Ingelheim Canada Digital Health Care Transformation Funding. MIMOSA Diagnostics, co-founded by Cross and Leung, has seen the device approved for clinical use in Canada and the U.S., marking a significant advancement in wound care technology.